MHMélèze Hocini

Mélèze Hocini

*This is an algorithmically generated author record based on publicly available information.

Mélèze Hocini has a total of 584 co-authors. Here are the top co-authors by number of shared publications:

  • Michel Haïssaguerre

    IHU Liryc, Electrophysiology and Heart Modeling Institute, Foundation Bordeaux Université, Bordeaux, France; Cardiac electrophysiology and stimulation, Cardiology Department, Bordeaux University Hospital (CHU), Pessac, France

    55 shared publications
  • Pierre Jaïs

    CHU de Bordeaux Hopital Cardiologique du Haut-Leveque Avenue de Magellan, 33600 Pessac

    46 shared publications
  • Frederic Sacher

    University Hospital Bordeaux, Pessac (M.Y., P.J., F.S.).

    44 shared publications
  • Nicolas Derval

    Department of Cardiac Pacing and Electrophysiology (G.D., N.J., L.V., A.P., F.N., K.B., J.L.F., K.K., K.V., C.M., M.T.-L., B.S., J.C., M.A., R.T., M. Hocini, M. Haïssaguerre, P.J., T.P., J.D., F.S., N.D.), Hôpital Cardiologique du Haut-Leveque, Bordeaux University Hospital, France

    36 shared publications
  • Josselin Duchateau

    Department of Cardiac Electrophysiology, Hôpital Cardiologique du Haut-Lévêque, Bordeaux University Hospital, Pessac, France; IHU LIRYC, Université de Bordeaux–Inserm U1045 , Pessac

    23 shared publications
  • Romain Tixier

    Department of Cardiac Pacing and Electrophysiology, Hopital Cardiologique du Haut-Leveque, Bordeaux University Hospital (CHU) , 1 Avenue de Magellan, Pessac Cedex 33604

    17 shared publications

Latest Publications

  • Open Access

    The future of PFA in cardiac ablation procedures

    by Jason G Andrade, Samuel J Asirvatham, Mélèze Hocini, Peter Karl Jacobsen, Nico Reinsch, Domenico G Della Rocca, Andrea Sarkozy, Nicholas Tan, Jason A Tri, Claudia Auricchio, et al.

    Pulsed field ablation (PFA) has rapidly emerged as a major development in catheter ablation, with increasing clinical adoption driven by procedural efficiency and a favorable safety profile compared with thermal energies. This article summarizes the future directions of PFA in electrophysiology, focusing on technological innovation, and how these advances are expected to expand PFA clinical indications. Additionally, this article provides a perspective on current gaps and future challenges of PFA. A perspective on future developments in new waveforms, catheter architectures, and integration with electroanatomical mapping systems for PFA is summarized. The document discusses novel waveform configurations and catheter design concepts that may improve lesion quality, procedural versatility, and safety. Additionally, this article also reviews how parallel advances in electroanatomical mapping integration, artificial intelligence, and robotic navigation are expected to enhance procedural guidance and enable individualized therapy. This manuscript summarizes the potential applications of PFA beyond pulmonary vein isolation and how emerging evidence supports its feasibility for linear atrial lesions, substrate modification, treatment of complex atrial tachycardias, and ventricular arrhythmia ablation. In addition, this article provides insights on how PFA may facilitate catheter ablation in new patient populations including elderly patients and those with higher procedural risks. Finally, this manuscript provides an outlook at major remaining challenges and knowledge gaps for PFA. The lack of homogenous procedural endpoints definitions and lesion durability assessment are discussed. Furthermore, this article highlights the need for standardized terminology and reporting in an environment where the high heterogeneity between available commercial systems complicates comparison across technologies.

  • Open Access

    Acute efficacy of a focal dual-energy contact force-sensing catheter vs. standard radiofrequency for anatomical ablation of persistent atrial fibrillation: a pilot study

    by Francesco Notaristefano, Nicolas Johner, Geoffroy Ditac, Allan Plant, Laurens Verhaeghe, John L Fitzgerald, Kinan Kneizeh, Karim Benali, Konstantinos Vlachos, Cinzia Monaco, et al.

  • Electrophysiological Mechanisms of Typical Atrial Flutter After Atrial Switch Operation: Critical Role of the Septal Corridor

    by Geoffroy Ditac, Nicolas Johner, Laurens Verhaeghe, Allan Plant, Francesco Notaristefano, Karim Benali, John L. Fitzgerald, Kinan Kneizeh, Konstantinos Vlachos, Cinzia Monaco, et al.

    BACKGROUND: Peritricuspid, or cavotricuspid isthmus–dependent, atrial flutter is the most common arrhythmia in patients with dextro-transposition of the great arteries treated with atrial switch surgery, but its underlying mechanisms remain poorly understood. METHODS: Twenty consecutive patients with prior atrial switch surgery referred for atrial flutter ablation were included. All underwent transbaffle puncture and high-density mapping. Anatomic barriers, activation patterns, conduction velocities, and low-voltage areas were assessed. RESULTS: In all cases of peritricuspid atrial flutter, surgical incisions defined the posterior boundary of the circuit. The narrowest segment of the reentry was consistently located within a septal corridor bounded posteriorly by the baffle incision and anteriorly by the tricuspid annulus. Slow conduction (<30 cm/s) was identified in this septal corridor in 92% of peritricuspid flutters and in 85% of patients during sinus or paced rhythm. Low-voltage areas were limited and frequently colocalized with regions of slow conduction. No patient exhibited slow conduction or low voltage at the cavotricuspid isthmus. The septal corridor was also involved in 60% of nonperitricuspid reentrant atrial tachycardias. Programmed atrial stimulation with S2 mapping accentuated conduction delay in this region, with demonstration of functional block and induction of atrial flutter. CONCLUSIONS: In patients with dextro-transposition of the great arteries corrected by atrial switch, surgical incisions define posterior boundaries and create a narrow septal corridor, or baffle-tricuspid isthmus, characterized by slow conduction and a propensity for functional block. These anatomic and electrophysiological features likely underlie the high prevalence of peritricuspid reentry in this population, representing a ubiquitous critical substrate for arrhythmia initiation and maintenance. Systematic cavotricuspid isthmus ablation should, therefore, be considered in these patients.


  • Ablation of Persistent Atrial Fibrillation Using a Dual-Energy Contact Force-sensing Catheter: Topography of Pulsed Field Mediated Symptoms and New Safety Challenges

    by Francesco Notaristefano, Nicolas Johner, Geoffroy Ditac, Allan Plant, Laurens Verhaeghe, John L. Fitzgerald, Kinan Kneizeh, Karim Benali, Konstantinos Vlachos, Cinzia Monaco, et al.


  • Open Access

    Role of Interatrial Connection Ablation in Reentry Dynamics: an in silico Evaluation

    by Patricia Martínez Díaz, Hamed Hosseini, Vladimír Sobota, Carmen Martínez Antón, Carlos López Barrera, Robin Van Den Abeele, Nele Vandersickel, Caroline Roney, Thomas Pambrun, Mélèze Hocini, et al.

    Background and Aims: Interatrial connections (IACs) may act as pathways sustaining atrial fibrillation, yet their role as ablation targets remains uncertain due to challenges in identifying IAC-dependent reentrant circuits. This study tracks reentrant activity along IACs, characterizes IAC-dependent reentries, and assesses the impact of in silico IAC ablation on reentry maintenance. Methods: Six patient-specific biatrial bilayer models were reconstructed from CT and MRI-derived geometries, each incorporating four IACs: Bachmann’s bundle, fossa ovalis, upper posterior, and coronary sinus. The Courtemanche ionic model was used to simulate mild (M) and severe (S) AF-related electrical remodeling, with fibrosis burden ranging from 9.0% (M) to 27.6% (S). Across the 12 models, 110 sustained reentries were induced, followed by circumferential pulmonary vein isolation. Fifteen IAC ablation strategies were tested at three different timings. Critical pathways along the six possible interatrial loops were quantified. Tachycardia cycle length (TCL) and phase singularity (PS) clusters were analyzed before and after IAC ablation. Results: Overall, 11.8% of reentries were IAC-dependent. Larger interatrial loops were the major contributors to critical pathway formation. IAC-dependent reentries exhibited more critical pathways, shorter TCL (194.2 vs 201.9 ms; ΔTCL=7.65 ms, p = 0.006), and more PS clusters in the RA body (8 [5–10] vs. 4 [2–6], p = 0.006). Ablation timing did not influence termination rates. Conclusion: We present the first framework to track reentrant activity along IACs. We identified IAC-dependent reentry characteristics that may guide patient stratification and targeted ablation strategies in clinical practice.

  • Open Access

    Incidence and type of recurrent ventricular arrhythmia in patients with arrhythmic mitral valve prolapse and implantable cardioverter defibrillator for secondary prevention

    by Kinan Kneizeh, Frederic Sacher, Francesco Notaristefano, Konstantinos Vlachos, Geoffroy Ditac, Josselin Duchateau, Freddy Del-Carpio Munoz, Krysztof Jaworski, Wael Alqarawi, Bert Vandenberk, et al.

    Aims: Mitral valve prolapse (MVP) is a common valvular disorder associated with ventricular arrhythmias (VAs) in a subgroup of patients, known as arrhythmic MVP (AMVP). Arrhythmic MVP patients with malignant VAs typically receive an implantable cardioverter-defibrillator (ICD) for secondary prevention. However, data regarding the incidence of appropriate ICD therapy and the type of arrhythmia recurrence in this population remain scarce. This study aimed to evaluate the incidence of appropriate ICD therapies and type of arrhythmia recurrence in AMVP patients with an ICD implanted for secondary prevention. Methods and results: A systematic literature search was conducted in PubMed/MEDLINE and EMBASE databases until January 2025. Studies reporting the incidence of appropriate ICD therapy in AMVP patients were included. A total of 9 studies met the inclusion criteria, resulting in 166 AMVP patients with ICDs for secondary prevention. The mean age was 41.8 years, with 55.8% of patients being female. Over a weighted mean follow-up of 4.9 ± 3.1 years, 34.9% [95% confidence interval (CI): 28.1–42.5] of the patients experienced recurrence of VA. The pooled incidence of appropriate ICD therapies during follow-up was 8.1 per 100 person-years (95% CI: 5.6–10.5, I2: 11.7%). Regarding the type of arrhythmic recurrence, the majority of arrhythmias (53.8%, 95% CI: 44.3–63.0%) were in the form of ventricular fibrillation or polymorphic ventricular tachycardia (VT), while the remaining arrhythmias were reported as monomorphic VT. Among 67 ventricular arrhythmic episodes reported in 7 studies with available data, 65 required shock therapy, corresponding to a shock proportion of 97.0% (95% CI: 89.6–99.6%). Conclusion: Arrhythmic MVP patients with ICDs for secondary prevention exhibit a high risk of recurrent arrhythmias, with recurrences in the form of polymorphic VA occurring in more than half of the cases. PROSPERO registration number: CRD42024588610


  • Top Cited Papers
    Open Access

    Computed tomography-guided vs conventional catheter ablation for ventricular tachycardia: the InEurHeart trial

    by Frederic Sacher, Tobias Reichlin, Mathieu Le Bloa, Gregoire Massoulie, Xavier Waintraub, Philippe Maury, Daniel Scherr, Romain Tixier, Benoit Guy-Moyat, Josselin Duchateau, et al.

    Background and Aims: Catheter ablation is performed in patients with recurrent ventricular tachycardia (VT) but remains complex and limited to experienced centres. Ventricular tachycardia ablation guided by pre-procedural imaging was shown promising in non-randomized trials. InEurHeart aims to evaluate computed tomography (CT)-guided VT ablation vs conventional ablation in a multicentre randomized controlled trial. Methods: In 14 European centres, 113 patients with prior myocardial infarction and clinically significant VT were randomly assigned to CT-guided (n = 57) or conventional (n = 56) VT ablation. The primary objective was to demonstrate reduced procedural duration when using CT guidance. Secondary endpoints included efficacy (incidence and burden of ventricular arrhythmia), safety, as well as composite endpoints. Results: The primary endpoint showed a significant decrease in procedure time favouring CT-guided ablation: 149 ± 51 to 120 ± 50 min, −19% [95% confidence interval (CI) −32; −7]; P = .0027 in intention to treat, and 149 ± 51 to 107 ± 38 min, −28% (95% CI −40; −16); P < .0001 per protocol. Major adverse events occurred in two (3.5%) in the conventional group vs one (1.8%) in the CT-guided group [−1.8% (95% CI −7.9; 4.3)]. Ventricular tachycardia–free survival at 1 year was achieved in 37 (67.3%) patients for conventional vs 43 (76.8%) for CT-guided VT ablation [9.5% (95% CI −10.4; 29.4), P = NS]. Ventricular tachycardia burden was decreased by 90% in the CT-guided group. Conclusions: In patients with ischaemic cardiomyopathy, CT-guided VT ablation reduces the procedure duration while maintaining a favourable efficacy and safety profile when compared with VT ablation without image integration.


  • Impact of Congenital Substrate 3D Imaging Reconstruction to Guide VT Catheter Ablation: The CORECA Study

    by Francis Bessière, Nicolas Combes, Hubert Cochet, Geoffroy Ditac, Laurence Iserin, Nicolas Derval, Robin Richard-Vitton, Benjamin Bouyer, Pauline Pinon, Stefano Bartoletti, et al.

    BACKGROUND: In the presence of sustained monomorphic ventricular tachycardia (VT), catheter ablation may be an option in congenital heart disease. However, the heterogeneity of underlying congenital heart disease and previous cardiac surgeries is associated with a unique and particularly complex substrate. The aim of the study was to investigate whether preprocedural 3-dimensional anatomic and substrate reconstruction based on cardiac computed tomography scan or magnetic resonance imaging could reliably identify VT substrate and ablation targets. METHODS: Consecutive patients with cardiac computed tomography or magnetic resonance imaging referred for VT ablation in 5 congenital electrophysiology centers were included. Three observers, electrophysiologists, blinded to the ablation procedure and each other, annotated potential ablation targets on 3-dimensional imaging reconstructions with a dedicated software (InHeart). Once completed, the annotations were compared between observers and with the ablation target(s) on the electroanatomical mapping generated during the procedures. RESULTS: Forty patients (mean age, 38±12 years; 67.5% male) underwent VT ablation, including 28 with a history of spontaneous sustained VT. VT was inducible in 97.5% of cases, with an acute success rate of ablation of 92.5%. Preprocedural imaging identified VT substrate in concordance with electroanatomical mapping in 87.5% of cases. There was a high degree of agreement between the observers. Positive interobserver agreement was complete in 65.0% of cases, moderate in 22.5%, and poor in 5.0%. Considering the total number of isthmuses identified by imaging in comparison with electroanatomical mapping, the sensitivity of imaging was 87.0%, and its positive predictive value was 77.0%. CONCLUSIONS: In our series, 3-dimensional anatomic reconstruction enabled identification of the critical VT substrate in most patients with complex congenital heart disease, particularly those with anatomically based reentrant circuits. Substrate target can be identified by operators with good interobserver reproducibility. This approach may guide VT ablation in these challenging cases.

  • MANIFEST-US

    by Mélèze Hocini

  • Open Access

    Idiopathic Ventricular Fibrillation: Substrates, Mechanisms and Treatment

    by Marine Arnaud, Josselin Duchateau, Mélèze Hocini

    Idiopathic VF is a complex clinical entity that is characterised by an evolving scope over time. Arrhythmogenic cardiomyopathy and electrical diseases represent a significant proportion of diagnoses attributed during follow-up in patients with an initial diagnosis of idiopathic VF. Stepwise diagnostic workup and management are of paramount importance. We proposed that idiopathic VF can be split into two distinct phenotypes, with potential overlap in an individual patient. In patients with Purkinje-related idiopathic VF, short-coupled ventricular ectopy can be documented, and ablation of the culprit tissue is a reasonable strategy to avoid recurrence. In patients with microstructural idiopathic VF, localised myocardial alterations can be unveiled by thorough electro-anatomical mapping and are amenable to a substrate-elimination strategy. Idiopathic VF is also a dynamic and evolving field, with promising research, new diagnostic tools and ablation techniques being developed in the near future.